Toumia, Imene Ben
Ponassi, Marco http://orcid.org/0000-0002-5418-2458
Barboro, Paola http://orcid.org/0000-0001-9074-9290
Iervasi, Erika http://orcid.org/0000-0002-7531-3373
Vargas, Gabriela Coronel http://orcid.org/0000-0002-7879-706X
Banelli, Barbara http://orcid.org/0000-0003-1505-7141
Fiordoro, Stefano
Ghedira, Leila Chekir
Kohnke, Franz Heinrich
Izzotti, Alberto http://orcid.org/0000-0002-8588-0347
Rosano, Camillo http://orcid.org/0000-0003-2949-9215
Funding for this research was provided by:
European Cooperation in Science and Technology (COST Action CA 17104 - STRATAGEM, COST Action CA16231 - ENOVA, COST Action CA 17104 - STRATAGEM)
Ministero della Salute (Ricerca Corrente 2021, 5x1000 2018-2019, 5x1000 2018-2019, Ricerca Corrente 2021)
Article History
Received: 11 May 2022
Accepted: 10 August 2022
First Online: 17 August 2022
Declarations
:
: All experiments on Balb/c mice (22–26 g) were performed following the European Communities Council Directive (86/609/EEC; November 24, 1986) regulating the welfare of experimental animals, and experiments were approved by the Life Sciences and Health Research Ethics Committee (cer-svs) of the Institute of Biotechnology (University of Monastir, Tunisia; ethical approval no. 2019/02/I/CER-SVS/ISBM; 9 January, 2019). Mice were housed under standard conditions in an accredited pathogen-free facility. All animals were provided access to filtered water and standard rodent chow ad libitum.
: C.R. is member of the Advisory Board of GIAM PHARMA International S.A.R.L., Monthey (CH). Other authors declare any conflict of interest.